Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -207.97% is 121% below its 5-year average of -94.09%, near the low end of its 5-year range (-212.93%–-54.61%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.38% below its 12-month average of -142.08%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -207.97%.
RETURN ON INVESTED CAPITAL (ROIC)
-207.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-142.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-123.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-94.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-46.38%
CURRENT VS 3Y AVG
-69.02%
CURRENT VS 5Y AVG
-121.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-25.42%
median of 377 covered companies
CURRENT VS SECTOR MEDIAN
-718.12%
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.42M
Return on Invested Capital (ROIC)
-207.97%
TTM Avg
-142.08%
3Y Avg
-123.04%
5Y Avg
-94.09%
Market Cap
$32.32M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-54.98%
3Y Avg
-73.47%
5Y Avg
-75.57%
Market Cap
$32.31M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-107.47%
3Y Avg
-107.47%
5Y Avg
-107.47%
Market Cap
$31.36M
Return on Invested Capital (ROIC)
-50.66%
TTM Avg
-13.98%
3Y Avg
7.71%
5Y Avg
25.88%
Market Cap
$35.89M
Return on Invested Capital (ROIC)
-10.09%
TTM Avg
-4.30%
3Y Avg
-1.90%
5Y Avg
0.50%
Market Cap
$30.92M
Return on Invested Capital (ROIC)
-126.84%
TTM Avg
-48.51%
3Y Avg
-88.12%
5Y Avg
-74.86%
Market Cap
$36.05M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$30.65M
Return on Invested Capital (ROIC)
-135.73%
TTM Avg
-98.73%
3Y Avg
-101.28%
5Y Avg
-89.83%
Market Cap
$36.31M
Return on Invested Capital (ROIC)
-249.58%
TTM Avg
-1007.23%
3Y Avg
-664.86%
5Y Avg
-535.30%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.42M | -207.97% | -142.08% | -123.04% | -94.09% |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | N/A | -54.98% | -73.47% | -75.57% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | N/A | -107.47% | -107.47% | -107.47% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -50.66% | -13.98% | 7.71% | 25.88% |
| Accuray Incorporated (ARAY)vs › | $35.89M | -10.09% | -4.30% | -1.90% | 0.50% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -126.84% | -48.51% | -88.12% | -74.86% |
| DocGo Inc. (DCGO)vs › | $36.05M | -89.44% | -27.62% | -11.28% | -9.71% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -135.73% | -98.73% | -101.28% | -89.83% |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | -249.58% | -1007.23% | -664.86% | -535.30% |
| Elutia Inc (ELUT)vs › | $36.32M | -79.27% | -43.87% | -333.47% | -212.56% |
ROIC
-208.0%
ROE
-238.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -207.97% |
| 2026-03-31 | -212.93% |
| 2025-12-31 | -122.08% |
| 2025-09-30 | -98.81% |
| 2025-06-30 | -68.60% |
| 2025-03-31 | -65.54% |
| 2024-12-31 | -184.37% |
| 2024-09-30 | -140.19% |
| 2024-06-30 | -109.71% |
| 2024-03-31 | -79.12% |
| 2023-12-31 | -69.05% |
| 2023-09-30 | -133.81% |
| 2023-06-30 | -107.33% |
| 2023-03-31 | -91.76% |
| 2022-12-31 | -85.93% |
| 2022-09-30 | -84.51% |
| 2022-06-30 | -84.16% |
| 2022-03-31 | -80.50% |
| 2021-12-31 | -65.33% |
| 2021-09-30 | -54.61% |
| 2021-06-30 | -62.25% |
| 2021-03-31 | -50.10% |
| 2020-12-31 | -41.63% |
| 2020-09-30 | -113.55% |
| 2020-06-30 | -56.21% |
| 2019-12-31 | -40.73% |
